Takahiro Akiyama Selected Research

Takahiro Akiyama Research Topics

Disease

6	Neoplasms (Cancer) 12/2020 - 02/2015
2	Ascites 01/2019 - 02/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 11/2017
2	Neoplasm Metastasis (Metastasis) 11/2017 - 11/2015
2	Leukopenia 10/2016 - 01/2016
2	Cytomegalovirus Infections (Inclusion Disease) 10/2016 - 01/2016
1	Fistula 10/2022
1	Thrombosis (Thrombus) 10/2022
1	Pathologic Constriction (Stenosis) 10/2022
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Adenocarcinoma 12/2020
1	Stomach Neoplasms (Stomach Cancer) 12/2020
1	Anemia 11/2017
1	Dihydropyrimidine Dehydrogenase Deficiency 11/2017
1	Leukemia 11/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2017
1	Neutropenia 11/2017
1	Pancytopenia 11/2017
1	Thrombocytopenia (Thrombopenia) 11/2017
1	Urinary Retention 01/2017
1	Anastomotic Leak 09/2016
1	Lymphatic Metastasis 11/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2015
1	Duodenal Ulcer (Curling's Ulcer) 11/2015
1	Heart Failure 02/2015
1	Underactive Urinary Bladder 01/2015
1	Infections 12/2013
1	Alzheimer Disease (Alzheimer's Disease) 02/2013
1	Nephritis 01/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2009
1	Atherosclerosis 10/2007
1	Uremia 10/2007
1	Hypertriglyceridemia 02/2005
1	Isolated Systolic Hypertension 02/2005
1	Hypercholesterolemia 02/2005
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2003
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 12/2003
1	Urinary Bladder Diseases (Bladder Diseases) 12/2003
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2003
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 12/2003
1	Wounds and Injuries (Trauma) 05/2002

Drug/Important Bio-Agent (IBA)

2	Z 338IBA 01/2017 - 01/2015
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2016 - 01/2016
2	mizoribineIBA 10/2016 - 01/2016
1	AntigensIBA 12/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Gemcitabine FDA Link 01/2019
1	Leucovorin (Folinic Acid)FDA Link 11/2017
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 11/2017
1	TegafurIBA 11/2017
1	dihydrouracilIBA 11/2017
1	UracilIBA 11/2017
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	Biological ProductsIBA 04/2016
1	Everolimus FDA Link 11/2015
1	DiureticsIBA 02/2015
1	Tolvaptan FDA Link 02/2015
1	distigmine (distigmine bromide)IBA 01/2015
1	Uric Acid (Urate)IBA 12/2013
1	Amyloid beta-PeptidesIBA 02/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2009
1	antiglomerular basement membrane antibodyIBA 01/2009
1	Indicators and Reagents (Reagents)IBA 10/2007

Therapy/Procedure

4	Therapeutics 11/2017 - 01/2009
3	Renal Dialysis (Hemodialysis) 10/2022 - 10/2007
3	Kidney Transplantation 01/2009 - 12/2003
2	Gastrectomy 12/2020 - 11/2015
2	Segmental Mastectomy (Lumpectomy) 12/2020 - 11/2015
2	Drug Therapy (Chemotherapy) 11/2017 - 11/2017
1	Colectomy 11/2017
1	Combined Modality Therapy 11/2017
1	Erythrocyte Transfusion 11/2017
1	Adjuvant Chemotherapy 11/2017
1	Catheters 01/2017
1	Esophagectomy 09/2016
1	Hepatectomy 11/2015
1	Pancreatectomy 11/2015
1	Transplantation 01/2009
1	Plasmapheresis 01/2009
1	Nephrectomy 05/2002
1	Conservative Treatment 05/2002